A seasoned operating executive, Elizabeth C. DeWan has built a notable career leading strategic initiatives in the healthcare sector. Her deep understanding of organizational dynamics and market needs allows her to drive transformative change in various business environments. Previously at the helm of major projects, she has been instrumental in enhancing operational efficiency while prioritizing patient care outcomes. With a robust network across healthcare stakeholders, she plays a vital role in aligning corporate goals with industry advancements and community health demands. Elizabeth's commitment to elevating standards within healthcare positions her as an influential figure amidst evolving market landscapes.
A seasoned operating executive, Elizabeth C. DeWan has built a notable career leading strategic initiatives in the healthcare sector. Her deep understanding of organizational dynamics and market needs allows her to drive transformative change in various business environments. Previously at the helm of major projects, she has been instrumental in enhancing operational efficiency while prioritizing patient care outcomes. With a robust network across healthcare stakeholders, she plays a vital role in aligning corporate goals with industry advancements and community health demands. Elizabeth's commitment to elevating standards within healthcare positions her as an influential figure amidst evolving market landscapes.
Market dynamics in the healthcare sector are evolving rapidly, and Elizabeth C. DeWan leverages her extensive executive experience to navigate these shifts effectively. Her focus on operational transformation is matched by a commitment to enhancing patient care through strategic initiatives. By utilizing a deep understanding of market requirements, she ensures alignment between organizational goals and emerging trends within the industry. With an eye for integrating innovative practices into traditional frameworks, there exists significant potential for operational improvements under her guidance. This unique blend of leadership acumen and market insight enables impactful decision-making that fosters growth while prioritizing community health outcomes.
Market dynamics in the healthcare sector are evolving rapidly, and Elizabeth C. DeWan leverages her extensive executive experience to navigate these shifts effectively. Her focus on operational transformation is matched by a commitment to enhancing patient care through strategic initiatives. By utilizing a deep understanding of market requirements, she ensures alignment between organizational goals and emerging trends within the industry. With an eye for integrating innovative practices into traditional frameworks, there exists significant potential for operational improvements under her guidance. This unique blend of leadership acumen and market insight enables impactful decision-making that fosters growth while prioritizing community health outcomes.
| Trades 2243 | Longs Won 1472/2243 65% | Profit Factor 4.35 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $305,915.56 |
| Average Win $82,226.38 | Best Trade (Aug 17) $10.04M | Sharpe Ratio -12.78 |
| Average Loss -$36,114.42 | Worst Trade (Dec 30) -$2.8M | Z-Score -5.26 (100%) |
| Commissions $0 | Avg. Trade Length 1y 4m 3w | Expectancy $46,353.27 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 7,463 | 6,716 | 5,970 | 5,224 | 4,478 | 3,731 | 2,985 | 2,239 | 1,493 | 746 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAAU Goldman Sachs Physical Gold ETF | 19,700 | $779,529 | $786,621 | - | $7,092 | 0.91% | -1.456% |
AAPL Apple Inc. | 23,547 | $4.07M | $7.27M | - | $3.2M | 78.68% | -7.354% |
ABBV AbbVie Inc. | 1,076 | $176,006.94 | $270,011.44 | - | $94,004.5 | 53.41% | -2.513% |
ABR Arbor Realty Trust Inc. | 28,600 | $334,860 | $143,286 | - | -$191,574 | -57.21% | +4.593% |
ABUS Arbutus Biopharma Corporation | 12,605 | $34,159.55 | $54,705.7 | - | $20,546.15 | 60.15% | -1.587% |
AGNCO AGNC Investment Corp. 10.1219% Perpetual Preferred Stock | 13,022 | $330,602.33 | $332,321.44 | - | $1,719.11 | 0.52% | +0.472% |
AMLP Alerian MLP ETF | 16,167 | $758,760.51 | $894,358.44 | - | $135,597.93 | 17.87% | +0.894% |
AMZN Amazon.com Inc | 7,792 | $1.33M | $2.12M | - | $782,453.79 | 58.67% | +15.321% |
AVDE Avantis International Equity ETF | 200,299 | $12.26M | $18.27M | - | $6.01M | 48.98% | -0.458% |
AVDV Avantis International Small Cap Value ETF | 97,070 | $5.96M | $10.16M | - | $4.19M | 70.3% | -0.476% |
AVEM Avantis Emerging Markets Equity ETF | 102,989 | $5.87M | $9.22M | - | $3.35M | 57.03% | +0.101% |
AVES Avantis Emerging Markets Value ETF | 6,150 | $303,681 | $382,776 | - | $79,095 | 26.05% | -0.749% |
AVGE FRCL 3 2022Q3 Hb Float | 18,268 | $1.29M | $1.8M | - | $513,579.48 | 39.78% | +0.071% |
AVGO Broadcom Inc. | 2,618 | $492,120.34 | $1.02M | - | $527,014.7 | 107.09% | +0.371% |
AVIG Avantis Core Fixed Income ETF | 46,422 | $1.93M | $1.89M | - | -$33,588.57 | -1.74% | -0.257% |
AVIV Avantis International Large Cap Value ETF | 4,450 | $236,053.5 | $359,159.5 | - | $123,106 | 52.15% | -0.567% |
AVLV Avantis U.S. Large Cap Value ETF | 46,186 | $2.7M | $4.26M | - | $1.55M | 57.45% | +0.141% |
AVMC Avantis U.S. Mid Cap Equity ETF | 16,300 | $1.05M | $1.29M | - | $244,658 | 23.32% | -0.289% |
AVMV Avantis U.S. Mid Cap Value ETF | 136,540 | $8.22M | $11.11M | - | $2.89M | 35.11% | -0.16% |
AVRE Avantis Real Estate ETF | 54,616 | $2.37M | $2.66M | - | $287,269.22 | 12.11% | -0.754% |